About Hipra India Private Limited
Data last updated:
Hipra India Private Limited is a private limited company based in Pune, Maharashtra, India, a subsidiary of Laboratorios Hipra Sa. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 14 February 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U85100PN2012PTC142264. Its GSTIN is 27AACCH8571J1Z6 (Maharashtra).
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹29.36 Cr. It is led by directors including Elia Torroella Busquets and Jameer Daulat Patel.
Its last annual general meeting (AGM) was held on 15 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.24 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹21.18 Lakh (net margin 0.6%) and EBITDA of ₹22.61 Lakh (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 58% over five years.
The company has about 22 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: HIPRA. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 3 cases are pending. The company has 7 deals on record (6 rights issues, 1 funding round), with disclosed funding of ₹44 Lakh; the latest was in June 2022. Its 3 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 1 larger and 2 smaller; the largest is Das Drugs Private Limited with revenue of ₹38.25 Cr. The company has 2 MSME Form 1 returns on record between 2019 and 2020, listing 14 overdue payments to 1 micro and small supplier.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hipra.com.
Company details
Contact details
Hipra India Private Limited's registered office is in Pune, Maharashtra. Its website is hipra.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressOffice No 609 A And 609 B, S. No. 23P 6th Floor Nandan Probiz, Pune, Maharashtra, India – 411045
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Hipra India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hipra India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hipra India Private Limited, buy the company report.
Financials of Hipra India Private Limited
FY 2025 filings availableHipra India Private Limited reported revenue of ₹38.24 Cr (up 40% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 58% over five years, including 40% growth in the latest year. EBITDA rose 108% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.61 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hipra India Private Limited, buy the company report.
Board of directors of Hipra India Private Limited
Hipra India has 7 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Elia Torroella Busquets | Director | 25 Nov 2013 | 12 Years 11 Months | Current |
| Jameer Daulat Patel Also directs: Socomore India Private Limited, Ecopack India Paper Cup Private Limited, Got Print Private Limited and 5 more | Director | 24 Apr 2014 | 12 Years 6 Months | Current |
| Maria Del Mar Nogareda Estivill | Director | 14 Feb 2012 | 14 Years 8 Months | Current |
| David Nogareda Estivill | Director | 14 Feb 2012 | 14 Years 8 Months | Current |
| Carlos Montanes Estupina | Director | 14 Feb 2012 | 14 Years 8 Months | Current |
| David Caballero Tomas | Director | 07 Jul 2025 | 1 Years 3 Months | Current |
Peer comparison
Hipra India Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Das Drugs Private Limited | ₹38.25 Cr (FY 2025) | 5.0% | Llucknow, Uttar Pradesh, India | |||
| Hipra India Private Limitedthis company | ₹38.24 Cr (FY 2025) | ₹21.18 Lakh | 0.6% | 40.0% | 22 | Pune, Maharashtra, India |
| Shree SSD Pharma Private Limited | ₹38.18 Cr (FY 2025) | 13.0% | Nagpur, Maharashtra, India | |||
| Tridoss Laboratories Private Limited | ₹38.05 Cr (FY 2025) | -13.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Hipra India Private Limited, buy the company report.
Auditor
Hipra India Private Limited is audited by UDYEN JAIN AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| UDYEN JAIN AND ASSOCIATES | FY 2023 | 116336W |
Shareholding
The shareholding of Hipra India Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hipra India Private Limited, buy the company report.
Deals & funding
Hipra India Private Limited has 7 deals on record (6 rights issues, 1 funding round), with disclosed funding of ₹44 Lakh; the latest was in June 2022.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2022 | Rights issue | ₹4.04 Cr | Investors: an individual |
| May 2021 | Rights issue | ₹6.88 Cr | Investors: an individual |
| Apr 2020 | Rights issue | ₹3.9 Cr | Investors: an individual |
| Jul 2019 | Rights issue | ₹2.81 Cr | Investors: an individual |
| Apr 2018 | Rights issue | ₹1.76 Cr | Investors: an individual |
To see the full deal history of Hipra India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Hipra India Private Limited has 4 court cases on record: 3 filed by Hipra India, 1 filed against it. 3 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 3 |
| High courts | 1 | 1 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed by the company against individuals | Pending |
| District court, Pune, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
| District court, Pune, Maharashtra | Court case (Spl.Sum.Suit) | Filed by the company against Astra Marketing Through Its Partners and 2 others | Pending |
| Bombay High Court | Writ petition | Filed against the company by an individual | Disposed |
To see the full case history of Hipra India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Hipra India Private Limited has 2 MSME Form 1 returns on record between 2019 and 2020, listing 14 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Udyen Jain & Associates |
To see the full MSME payment records of Hipra India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Hipra India Private Limited has a workforce of 22 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Hipra India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCH8571J1Z6 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hipra India Private Limited, buy the company report.
Recent activity
Hipra India Private Limited has 13 board changes on record since 2012: 7 appointments and 6 cessations. The latest: David Caballero Tomas ceased to be Additional Director on 14 Sep 2025.
4 earlier events are in the company report.
News
Frequently asked questions
Hipra India is an active private limited company based in Pune, Maharashtra, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 14 February 2012 (14+ years old) and is registered under CIN U85100PN2012PTC142264.
Hipra India has 7 current directors:
- Elia Torroella Busquets - Director
- Jameer Daulat Patel - Director
- Maria Del Mar Nogareda Estivill - Director
- David Nogareda Estivill - Director
- Carlos Montanes Estupina - Director
- David Caballero Tomas - Director
- Peter Cyriel A Saey - Director
The latest financial statements of Hipra India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hipra India is 27AACCH8571J1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Hipra India is U85100PN2012PTC142264. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hipra India has 4 court cases on record: 3 filed by the company and 1 filed against it. 3 are pending. Most are in the district courts.
Hipra India was incorporated on 14 February 2012, making it 14+ years old. It is registered with the Registrar of Companies, Pune.
Hipra India has 7 deals on record (6 rights issues, 1 funding round), with disclosed funding of ₹44 Lakh; the latest was in June 2022.
The peers of Hipra India by revenue are Das Drugs Private Limited, Shree SSD Pharma Private Limited, Tridoss Laboratories Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
David Caballero Tomas ceased to be Additional Director on 14 Sep 2025. Peter Cyriel A Saey ceased to be Additional Director on 14 Sep 2025. David Caballero Tomas was appointed as Director on 07 Jul 2025. Hipra India has 13 board changes on record in total.
Hipra India has 2 MSME Form 1 returns on record between 2019 and 2020, listing 14 overdue payments to 1 micro and small supplier. The latest return was filed on 15 Sep 2020.
Hipra India can be reached through the website hipra.com. Its registered office is in Pune, Maharashtra, India.